Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 3544469)

Published in Arterioscler Thromb Vasc Biol on November 01, 2012

Authors

Kelly E Beazley1, Derek Banyard, Florence Lima, Stephanie C Deasey, Dmitry I Nurminsky, Mikhail Konoplyannikov, Maria V Nurminskaya

Author Affiliations

1: Department of Biochemistry and Molecular Biology, University of Maryland, School of Medicine, 108 N Greene St, Baltimore, MD 21021, USA.

Articles cited by this

Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev (2004) 16.52

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature (1997) 7.10

Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem (2006) 6.32

Vascular calcification: pathobiology of a multifaceted disease. Circulation (2008) 3.64

Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res (2009) 3.53

Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest (2005) 3.00

Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol (2006) 2.95

Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol (2004) 2.90

Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol (1998) 2.49

A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol (2007) 2.21

Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res (2008) 2.19

Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun (2005) 1.78

Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int (2005) 1.77

Bone Gla protein increases HIF-1alpha-dependent glucose metabolism and induces cartilage and vascular calcification. Arterioscler Thromb Vasc Biol (2011) 1.69

Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood (2007) 1.62

The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr (2003) 1.61

Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr (2009) 1.52

Quercetin reduces blood pressure in hypertensive subjects. J Nutr (2007) 1.51

Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med (2006) 1.49

Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost (2007) 1.38

Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod Craniofac Res (2005) 1.36

Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol (2003) 1.35

Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res (2010) 1.30

The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res (2011) 1.29

Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res (2010) 1.29

Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis (2011) 1.25

Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest (2009) 1.24

Non-conventional Frizzled ligands and Wnt receptors. Dev Growth Differ (2008) 1.20

Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J Vasc Res (2008) 1.16

Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles. J Med Chem (2006) 1.07

Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett (2008) 1.06

Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr (2011) 1.03

A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertens (2003) 1.03

Notch signaling in cardiovascular disease and calcification. Curr Cardiol Rev (2008) 1.01

Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification. J Biol Chem (2011) 0.98

Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia. Am J Physiol Cell Physiol (2009) 0.98

Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists. Blood Rev (2012) 0.98

Association of warfarin use with valvular and vascular calcification: a review. Clin Cardiol (2011) 0.95

Transglutaminase 2-mediated activation of β-catenin signaling has a critical role in warfarin-induced vascular calcification. Arterioscler Thromb Vasc Biol (2011) 0.91

Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension. J Hypertens (2002) 0.90

Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. Am J Physiol Heart Circ Physiol (2012) 0.90

Interactions between quercetin and warfarin for albumin binding: A new eye on food/drug interference. Chirality (2010) 0.90

Vegetable flavonoids and cardiovascular disease. Asia Pac J Clin Nutr (2008) 0.90

Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteoblasts in vitro. Eur J Pharmacol (2004) 0.89

Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway. Atherosclerosis (2010) 0.88

The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability? Clin Dev Immunol (2007) 0.87

Calcification locates to transglutaminases in advanced human atherosclerotic lesions. Am J Pathol (2009) 0.87

Alpha-defensins increase lung fibroblast proliferation and collagen synthesis via the beta-catenin signaling pathway. FEBS J (2009) 0.85

Fluorescent probes of tissue transglutaminase reveal its association with arterial stiffening. Chem Biol (2010) 0.85

Tissue-specific responses to loss of transglutaminase 2. Amino Acids (2011) 0.83

Targeting intercellular signals for bone regeneration from bone marrow mesenchymal progenitors. Cell Cycle (2008) 0.82

Implication for transglutaminase 2-mediated activation of β-catenin signaling in neointimal vascular smooth muscle cells in chronic cardiac allograft rejection. J Heart Lung Transplant (2012) 0.80

Gender differences in coronary arteries and thoracic aorta calcification. Arterioscler Thromb Vasc Biol (2007) 0.79

Quercetin-crosslinked porcine heart valve matrix: mechanical properties, stability, anticalcification and cytocompatibility. Acta Biomater (2009) 0.76

Articles by these authors

Large clusters of co-expressed genes in the Drosophila genome. Nature (2002) 3.76

Lipotransfer: the potential from bench to bedside. Ann Plast Surg (2014) 1.98

VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med (Berl) (2008) 1.67

Lack of global meiotic sex chromosome inactivation, and paucity of tissue-specific gene expression on the Drosophila X chromosome. BMC Biol (2011) 1.31

Regulated chromatin domain comprising cluster of co-expressed genes in Drosophila melanogaster. Nucleic Acids Res (2005) 1.18

Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I. J Bone Miner Res (2007) 1.06

The nuclear lamina as a gene-silencing hub. Curr Issues Mol Biol (2011) 1.03

The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter. Bone (2011) 1.02

Skeletal myoblasts for cardiac repair. Regen Med (2010) 0.95

Transcriptional regulation by Modulo integrates meiosis and spermatid differentiation in male germ line. Proc Natl Acad Sci U S A (2006) 0.92

Transglutaminase 2-mediated activation of β-catenin signaling has a critical role in warfarin-induced vascular calcification. Arterioscler Thromb Vasc Biol (2011) 0.91

Analysis of the Drosophila melanogaster testes transcriptome reveals coordinate regulation of paralogous genes. Genetics (2008) 0.89

Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein. J Biol Chem (2012) 0.84

Comparison of the cytotoxic effects of beta-sitosterol oxides and a cholesterol oxide, 7beta-hydroxycholesterol, in cultured mammalian cells. Br J Nutr (2003) 0.84

The pattern of chromosome folding in interphase is outlined by the linear gene density profile. Mol Cell Biol (2005) 0.83

Mapping of transcription start sites by direct sequencing of SMART RACE products. Biotechniques (2003) 0.83

Nuclear ferritin: a ferritoid-ferritin complex in corneal epithelial cells. Invest Ophthalmol Vis Sci (2009) 0.83

Major histocompatibility complex-I expression on embryonic stem cell-derived vascular progenitor cells is critical for syngeneic transplant survival. Stem Cells (2010) 0.82

Attenuation of chondrogenic transformation in vascular smooth muscle by dietary quercetin in the MGP-deficient mouse model. PLoS One (2013) 0.81

Implication for transglutaminase 2-mediated activation of β-catenin signaling in neointimal vascular smooth muscle cells in chronic cardiac allograft rejection. J Heart Lung Transplant (2012) 0.80

Role of histone deacetylases in gene regulation at nuclear lamina. PLoS One (2012) 0.79

A fluid collection system for dermal wounds in clinical investigations. Biomicrofluidics (2016) 0.79

FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis. Clin Nephrol (2014) 0.78

Up-regulation of the Ku heterodimer in Drosophila testicular cyst cells. FEBS Lett (2007) 0.78

Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin. J Biol Chem (2013) 0.77

Partial weight bearing does not prevent musculoskeletal losses associated with disuse. Med Sci Sports Exerc (2013) 0.77

Strategic sequences in fat graft survival. Ann Plast Surg (2015) 0.76

Binding of pro-migratory serum factors to electrospun PLLA nano-fibers. J Biomater Sci Polym Ed (2013) 0.75

Effective expression of recombinant cytotoxic protein via its attachment to a polyglutamine domain. OMICS (2009) 0.75

New therapeutic approaches to arterial calcification via inhibition of transglutaminase and β-catenin signaling. Curr Pharm Des (2014) 0.75